Copyright
©The Author(s) 2022.
World J Clin Oncol. Jan 24, 2022; 13(1): 9-27
Published online Jan 24, 2022. doi: 10.5306/wjco.v13.i1.9
Published online Jan 24, 2022. doi: 10.5306/wjco.v13.i1.9
Figure 1 Major molecular signaling pathways involved in thyroid carcinogenesis and its most significant inhibitors.
Figure 2 Proposed decision-making algorithm for systemic therapy initiation in radioiodine refractory-differentiated thyroid carcinoma.
- Citation: Pitoia F, Jerkovich F, Trimboli P, Smulever A. New approaches for patients with advanced radioiodine-refractory thyroid cancer. World J Clin Oncol 2022; 13(1): 9-27
- URL: https://www.wjgnet.com/2218-4333/full/v13/i1/9.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i1.9